These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18218718)

  • 1. Conformational pH dependence of intermediate states during oligomerization of the human prion protein.
    Gerber R; Tahiri-Alaoui A; Hore PJ; James W
    Protein Sci; 2008 Mar; 17(3):537-44. PubMed ID: 18218718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligomerization of the human prion protein proceeds via a molten globule intermediate.
    Gerber R; Tahiri-Alaoui A; Hore PJ; James W
    J Biol Chem; 2007 Mar; 282(9):6300-7. PubMed ID: 17210575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR characterization of the pH 4 beta-intermediate of the prion protein: the N-terminal half of the protein remains unstructured and retains a high degree of flexibility.
    O'Sullivan DB; Jones CE; Abdelraheim SR; Thompsett AR; Brazier MW; Toms H; Brown DR; Viles JH
    Biochem J; 2007 Jan; 401(2):533-40. PubMed ID: 16958619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The presence of valine at residue 129 in human prion protein accelerates amyloid formation.
    Baskakov I; Disterer P; Breydo L; Shaw M; Gill A; James W; Tahiri-Alaoui A
    FEBS Lett; 2005 May; 579(12):2589-96. PubMed ID: 15862295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-induced molten globule state of a prion protein: crucial role of Strand 1-Helix 1-Strand 2 segment.
    Honda RP; Yamaguchi KI; Kuwata K
    J Biol Chem; 2014 Oct; 289(44):30355-30363. PubMed ID: 25217639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methionine oxidation perturbs the structural core of the prion protein and suggests a generic misfolding pathway.
    Younan ND; Nadal RC; Davies P; Brown DR; Viles JH
    J Biol Chem; 2012 Aug; 287(34):28263-75. PubMed ID: 22654104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein amyloid formation under native-like conditions involves refolding of the C-terminal alpha-helical domain.
    Cobb NJ; Apetri AC; Surewicz WK
    J Biol Chem; 2008 Dec; 283(50):34704-11. PubMed ID: 18930924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of disulfide bridge in the folding and stability of the recombinant human prion protein.
    Maiti NR; Surewicz WK
    J Biol Chem; 2001 Jan; 276(4):2427-31. PubMed ID: 11069909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
    Hornemann S; Glockshuber R
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal domain of prion protein directs its oligomeric association.
    Trevitt CR; Hosszu LL; Batchelor M; Panico S; Terry C; Nicoll AJ; Risse E; Taylor WA; Sandberg MK; Al-Doujaily H; Linehan JM; Saibil HR; Scott DJ; Collinge J; Waltho JP; Clarke AR
    J Biol Chem; 2014 Sep; 289(37):25497-508. PubMed ID: 25074940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple folding pathways for heterologously expressed human prion protein.
    Jackson GS; Hill AF; Joseph C; Hosszu L; Power A; Waltho JP; Clarke AR; Collinge J
    Biochim Biophys Acta; 1999 Apr; 1431(1):1-13. PubMed ID: 10209273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-dependent stability and conformation of the recombinant human prion protein PrP(90-231).
    Swietnicki W; Petersen R; Gambetti P; Surewicz WK
    J Biol Chem; 1997 Oct; 272(44):27517-20. PubMed ID: 9346881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
    Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
    Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic equilibria between monomeric and oligomeric misfolded states of the mammalian prion protein measured by 19F NMR.
    Larda ST; Simonetti K; Al-Abdul-Wahid MS; Sharpe S; Prosser RS
    J Am Chem Soc; 2013 Jul; 135(28):10533-41. PubMed ID: 23781904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding of prion protein to its native alpha-helical conformation is under kinetic control.
    Baskakov IV; Legname G; Prusiner SB; Cohen FE
    J Biol Chem; 2001 Jun; 276(23):19687-90. PubMed ID: 11306559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.